Shan Liang
National Center for Biotechnology Information, NLM, NIH
Magnetic resonance spectroscopy (MRS) is a technique that allows us to non-invasively detect multiple small metabolites within cells or extracellular spaces (1, 2). The clinical use of MRS as an adjunct to magnetic resonance imaging (MRI), particularly in cancer detection and treatment response evaluation, has expanded dramatically over the past several years. Although MRS is theoretically applicable to any nucleus possessing spin, the most important and more frequently investigated applications are in proton (H) and carbon-13 (C) (1, 3, 4). C MRS is superior to H MRS in many respects (5-7). C MRS can provide specific information about the identity and structure of biologically important compounds. The chemical shift range for carbon (250 ppm) is much larger than that for proton (15 ppm), allowing for improved resolution of metabolites. In addition, the T relaxation time of C in small molecules is much longer than that of H (0.1–2.0 s in a magnetic field of 0.1–3.0 T), allowing the generation of hyperpolarized C-labeled tracers outside the subject and the MRI scanner. Some of these tracers are endogenous and therefore have lower toxicity than drugs and exogenous contrast media (2). However, C MRS is limited by the low natural abundance of C (1.1%) and its low magnetogyric ratio (γ of C is one quarter that of H) (1, 6). Several techniques have been used to overcome the C MRS limitation through enhancing the polarization of nuclear spins. One technique is proton decoupling, which eliminates the coupling of H with C by irradiating the entire H resonance absorption range and consequently collapsing C resonances to singlets (8, 9). The signal/noise ratio of C resonances has been shown to be significantly increased with proton decoupling. Another technique is known as dynamic nuclear polarization (DNP), which introduces one or more C molecules into a metabolic substrate (3, 10, 11). DNP transfers high electron spin polarization to nuclear spins microwave irradiation. Nearly 100% nuclear polarization for H and 50% for C can be achieved in various organic molecules when DNP is performed in a strong magnetic field and at cryogenic temperatures. Hyperpolarization of protons ex vivo is less interesting for medical applications, because most of the hyperpolarization would have vanished before the molecule reaches the target organ. However, the T of C in small molecules, in general, is much longer than the T of protons. A large number of low molecular weight substances with C T in excess of 10 s are available. Replacing the C isotope (98.9% natural abundance) with the C isotope at a specific carbon or carbons in a metabolic substrate does not affect the substrate's biochemistry. With C MRS, the body tissues are virtually invisible, and only regions where the hyperpolarized C-labeled substance is present will appear in the generated images. Thus, C-labeled substrates can provide >10,000-fold enhancement of the C MRS signals from the substrate and its subsequent metabolic products, allowing the assessment of changes in metabolic fluxes through glycolysis, citric acid cycle, and fatty acid synthesis (2, 11, 12). Vascular and perfusion imaging can also be performed without background signal from surrounding tissues (6, 13). Karlsson et al. generated a hyperpolarized small molecule, α-keto[1-C]isocaproate ([1-C]KIC) as a C MRS agent for imaging the molecular signature of branched chain amino acid metabolism, which is regulated by the branched chain amino acid transferase (BCAT) (5). There are two isoforms, BCAT1 and BCAT2, that code for mitochondrial and cytosolic BCAT, respectively (5, 14). BCAT is highly expressed in early embryogenesis, and it is also a target for MYC activity during oncogenesis. BCAT has been shown to be a useful marker for grading and genetic characterization of tumors. KIC is a substrate of BCAT and is metabolized to leucine . Karlsson et al. demonstrated that metabolism of the hyperpolarized [1-C]KIC yielded unprecedented MRI contrast between EL4 murine lymphoma and surrounding healthy tissue, but yielded no contrast between R3230AC rat mammary adenocarcinoma and its surrounding tissue. The [1-C]leucine signal detected in the two tumor models correlated well with measurements of the BCAT activity in the two tumor tissues. The investigators concluded that the understanding of metabolic differences between tumors could be advanced with use of the hyperpolarized [1-C]KIC biomarker in assessing tissue BCAT activity by means of the [1-C]leucine signal (5).
磁共振波谱学(MRS)是一种使我们能够非侵入性地检测细胞内或细胞外空间中多种小代谢物的技术(1, 2)。在过去几年中,MRS作为磁共振成像(MRI)的辅助手段在临床中的应用,尤其是在癌症检测和治疗反应评估方面,有了显著扩展。虽然从理论上讲,MRS适用于任何具有自旋的原子核,但最重要且研究更频繁的应用是针对质子(H)和碳 - 13(C)(1, 3, 4)。碳 - 13磁共振波谱(C MRS)在许多方面优于质子磁共振波谱(H MRS)(5 - 7)。C MRS可以提供有关生物重要化合物的身份和结构的特定信息。碳的化学位移范围(约250 ppm)比质子的化学位移范围(约15 ppm)大得多,这使得代谢物的分辨率得以提高。此外,小分子中碳的T1弛豫时间比氢长得多(在0.1 - 3.0 T的磁场中为0.1 - 2.0 s),这使得可以在受试者体外和MRI扫描仪外生成超极化的碳标记示踪剂。其中一些示踪剂是内源性的,因此比药物和外源性造影剂的毒性更低(2)。然而,C MRS受到碳的天然丰度低(1.1%)及其低磁旋比(碳的γ是氢的四分之一)的限制(1, 6)。已经使用了几种技术来通过增强核自旋的极化来克服C MRS的限制。一种技术是质子去耦,通过照射整个氢共振吸收范围消除氢与碳的耦合,从而使碳共振坍缩为单峰(8, 9)。质子去耦已被证明可显著提高碳共振的信噪比。另一种技术称为动态核极化(DNP),它将一种或多种碳分子引入代谢底物中(3, 10, 11)。通过微波照射,DNP将高电子自旋极化转移到核自旋上。当在强磁场和低温下进行DNP时,在各种有机分子中可以实现氢的近100%核极化和碳的50%核极化。对于医学应用而言,体外质子的超极化不太有意义,因为在分子到达靶器官之前,大部分超极化就会消失。然而,一般来说,小分子中碳的T1比质子的T1长得多。有大量低分子量物质的碳T1超过10 s。在代谢底物的特定一个或多个碳原子处用碳 - 13同位素(天然丰度98.9%)取代碳 - 12同位素不会影响底物的生物化学性质。使用C MRS时,身体组织实际上是不可见的,只有存在超极化碳标记物质的区域才会出现在生成的图像中。因此,碳标记的底物可以使来自底物及其后续代谢产物的C MRS信号增强超过10000倍,从而能够评估通过糖酵解、柠檬酸循环和脂肪酸合成的代谢通量变化(2, 11, 12)。还可以在没有周围组织背景信号的情况下进行血管和灌注成像(6, 13)。卡尔松等人生成了一种超极化的小分子α - 酮[1 - C]异己酸酯([1 - C]KIC)作为C MRS试剂,用于成像由支链氨基酸转氨酶(BCAT)调节的支链氨基酸代谢的分子特征(5)。有两种同工型,BCAT1和BCAT2,分别编码线粒体和胞质BCAT(5, 14)。BCAT在早期胚胎发育中高度表达,并且在肿瘤发生过程中也是MYC活性的靶点。BCAT已被证明是肿瘤分级和基因特征分析的有用标志物。KIC是BCAT的底物,可代谢为亮氨酸。卡尔松等人证明,超极化的[1 - C]KIC的代谢在EL4小鼠淋巴瘤与其周围健康组织之间产生了前所未有的MRI对比度,但在R3230AC大鼠乳腺腺癌与其周围组织之间未产生对比度。在两个肿瘤模型中检测到的[1 - C]亮氨酸信号与两个肿瘤组织中BCAT活性的测量结果相关性良好。研究人员得出结论,通过使用超极化的[1 - C]KIC生物标志物,借助[1 - C]亮氨酸信号评估组织BCAT活性,可以加深对肿瘤之间代谢差异的理解(5)。